Actuate Therapeutics, Inc. (ACTU) SEC Filings — 2024
13 SEC filings for Actuate Therapeutics, Inc. (ACTU) in 2024.
Filings
- Actuate Therapeutics Files 8-K — 8-K · Dec 17, 2024
- Actuate Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
- Actuate Therapeutics Files 8-K — 8-K · Nov 12, 2024
- Actuate Therapeutics Files Q2 2024 10-Q — 10-Q · Sep 24, 2024
- BIOS Group Discloses Stake in Actuate Therapeutics — SC 13D · Aug 19, 2024
- Actuate Therapeutics Appoints BDO USA as New Auditor — 8-K · Aug 19, 2024
- Actuate Therapeutics Files 8-K with Officer, Director, and Bylaw Updates — 8-K · Aug 14, 2024
- Actuate Therapeutics Files IPO Amendment — S-1/A · Jul 23, 2024
- Actuate Therapeutics Files S-1/A Amendment — S-1/A · Jul 19, 2024
- Actuate Therapeutics Files S-1/A for IPO — S-1/A · Jul 16, 2024
- Actuate Therapeutics Files S-1/A for IPO — S-1/A · Jun 21, 2024
- Actuate Therapeutics Files S-1/A Amendment — S-1/A · Jun 11, 2024
- Actuate Therapeutics Files for IPO — S-1 · May 24, 2024